Chinese Hawthorn for Health & Longevity

Created on 11/06/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Chinese hawthorn is an East Asian tree's red fruit, eaten as food and used in Chinese medicine for digestion, cholesterol and blood pressure. Species-specific evidence is thin; it is an inexpensive dietary addition with plausible but largely unproven heart and metabolic benefits. Safety is generally reassuring at food and supplement amounts, though large amounts of fresh fruit can form bowel-blocking masses; reports tie it to excessive anti-clotting effects with warfarin. (Full Review)

Protocol

Traditional dried-fruit dose
9–12 g dried fruit
Two to three times daily as decoction or tea; with or after meals for digestive use
Fruit-extract powder
900 mg/day
Once daily, 2 hours before bedtime; skin-trial regimen
Leaf-and-citrus mixture
840–1,200 mg/day
Leaf plus citrus peel extract in three doses; body-fat-trial regimen
Time to effect
Skin hydration
6 months
With fruit-extract powder
Body fat
12 weeks
With the leaf-and-citrus mixture
Cardiovascular effects
4–8 weeks
Allowed by practitioners; trials assessed lipids at 8–12 weeks

Benefits

Contraindications
  • History of bezoar, gastrointestinal surgery or gastroparesis
  • Heart failure with left-ventricular ejection fraction ≤35%, unless supervised by a cardiologist
  • Known allergy to rose-family plants
  • Pregnancy
  • Active peptic ulcer or erosive gastritis
Key Interactions
  • Warfarin and other anticoagulants (apixaban)
Theoretical (inferred from mechanism)
  • Nitrates and PDE5 inhibitors (nitroglycerin, sildenafil)
  • Antiplatelet drugs (aspirin, clopidogrel)
  • Lipid-lowering drugs (atorvastatin, ezetimibe)
  • Over-the-counter NSAIDs (ibuprofen)
  • Supplements with additive effects (garlic, ginkgo)
  • Persimmon and other high-tannin fruit in large amounts

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal discomfort and dizziness; phytobezoar and bowel obstruction; early heart-failure progression; allergic hypersensitivity reaction; toxicity from mislabeled "hawthorn" products; increased bleeding tendency
  • Speculative: Pregnancy concerns

Monitoring

Marker Target Why
LDL cholesterol <100 mg/dL Expected to change
Triglycerides <150 mg/dL Expected to change
Blood pressure (home) <120/80 mmHg Expected to change; safety check for low readings
ALT Approximately 7–56 U/L Expected to change in fatty liver
Digoxin level (if prescribed) No established target; track change from own baseline on an unaffected assay Safety check
INR (if taking warfarin) No established target for hawthorn users; track change from own baseline within the prescriber's therapeutic range Safety check
Body weight Not specified in the ER Body-composition baseline
Waist circumference Not specified in the ER Body-composition baseline
Total cholesterol Not specified in the ER Paired with LDL
HDL Not specified in the ER Paired with LDL
AST Not specified in the ER Paired with ALT
GGT Not specified in the ER Paired with ALT

Cadence: Baseline before starting; lipid panel and liver enzymes typically at 8–12 weeks, then every 6–12 months; home blood pressure twice weekly for the first 4 weeks, then monthly; INR within 1–2 weeks of starting for warfarin users

Qualitative Assessment

  • Digestive comfort after meals, bloating and stool regularity
  • Dizziness or light-headedness on standing
  • Exercise tolerance and breathlessness, especially in heart failure
  • Skin dryness or hydration
  • Energy and sleep quality